hepatitis c virus
IL28B gene predicts treatment outcome for liver transplantation patients
German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a m…
Lack of health insurance limits hepatitis C patients’ access to latest antiviral therapy
New research has determined that patients in the U.S. with hepatitis C virus (HCV) are twice as likely to not have health insurance coverage compared with those without the disease. In fact researchers found only a third of HCV infected Americans ha…
New vaccine technology protects mice from hepatitis C virus
Immunology: Three percent of the world’s population is currently infected by hepatitis C. The virus hides in the liver and can cause cirrhosis and liver cancer, and it’s the most frequent cause of liver transplants in Denmark. Since the virus mutate…
Study finds little decline in hepatitis C infections among injection drug users
[EMBARGOED FOR JAN. 31, 2011] A recent 20-year study of injection drug users (IDUs) in Baltimore found a significant decline in new cases of HIV infection but only a slight decline in new cases of hepatitis C virus (HCV) infection. The findings sugg…